S-Biomedic
Ghent
About S-Biomedic
S-Biomedic brings novel therapeutic solutions to the skin microbiome.The skin microbiome - a habitat of billions of beneficial and harmful bacteria - contributes to healthy skin. An imbalance of these bacteria can lead to a variety of skin conditions including acne, eczema, rosacea and ageing. S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries. They design their products using the latest advances in microbiology and dermatology. Using their technology, beneficial bacteria are selected and combined to generate products that accelerate the rebalancing of a disease microbiome. In this way, they are able to restore a healthy state back to your skin.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $6.1M
- Funding stage: M&A
- Last round: Grant (Oct 2019)
- Website: sbiomedic.com
- Phone: +32 477 269940
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/s-biomedic-124414 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.